SEC Form D filing

Oncotelic Therapeutics, Inc., 2025-12-11

An SEC Form D private-offering notice from Agoura Hills, CA, a $12,500,000 filer-stated offering target in Biotech. Filed 2025-12-11. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Oncotelic Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage immuno oncology company developing RNA therapeutics and small molecule drugs against cancer and infectious diseases, publicly traded as OTLC

Filed 2025-12-11Filed to raise $12,500,000First money in 2025-12-04Raised so far $275,000HQ (as filed) Agoura Hills, CASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified oncotelic.com↗Named in the filing 1 executive & director
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source